查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032665

自動注射器市場報告：按類型、應用程式、最終用戶和地區分類（2026-2034 年）

Autoinjector Market Report by Type (Disposable Autoinjectors, Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), End User (Home Care Settings, Hospitals and Clinics), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年全球自動注射器市場規模達29億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到87億美元，2026年至2034年的複合年成長率將達到12.67%。慢性病盛行率上升、生物製藥和生物相似藥的持續進步、對居家醫療的日益重視、眾多產品創新以及有利的報銷政策是推動市場成長的因素。

自動注射器是一種輔助皮下或肌肉注射藥物的自行注射裝置。它們具有許多優勢，包括提高劑量準確性和患者遵守用藥、減輕患者對針頭的恐懼、最大程度減少因針頭隱蔽造成的針刺傷，以及提升醫護人員的便利性和工作效率。自動注射器廣泛應用於各種緊急情況，例如過敏性休克、偏頭痛、癲癇持續狀態、乾癬、糖尿病、多發性硬化症和類風濕性關節炎。因此，自動注射器在全球各地的醫院、診所和居家照護中心廣泛使用。

自動注射器市場的發展趨勢：

目前，關節炎、氣喘、癌症、慢性阻塞性肺病（COPD）和阿茲海默症的盛行率呈上升趨勢。此外，自我用藥需求的增加也是推動市場成長的主要因素之一。許多國家的政府正在努力推廣在學校使用自動注射器。這些因素，加上人們對自動注射器益處的認知不斷提高，共同促進了市場成長。主要市場參與者也大力投資研發，以開發用於治療類風濕性關節炎和多發性硬化症的簡單、經濟且創新的自動注射器。此外，標靶治療的日益普及，例如改變癌細胞內的蛋白質並阻止腫瘤內新生血管的形成，也為行業投資者提供了極具吸引力的成長機會。快速發展的全球醫療保健產業也在推動市場成長。其他成長要素包括監管核准的增加、技術進步、生物製藥專利到期以及自動注射器學名藥的上市。

市場區隔:

本報告分析了各細分市場的關鍵趨勢，並對2026年至2034年全球、區域和國家的市場進行了預測。報告根據類型、應用和最終用戶對市場進行了分類。

按類型細分：

  • 一次性自動注射器
  • 可重複使用的自動注射器

按用途細分：

  • 類風濕性關節炎
  • 過敏反應
  • 多發性硬化症
  • 其他

按最終用戶細分：

  • 居家醫療
  • 醫院和診所

按地區分類：

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局：

此外，還調查了該行業的競爭格局，以及安進、安泰製藥、貝克頓·迪金森、百時美施貴寶、Eisai、禮來公司、哈塞爾邁爾（蘇爾壽）、強生、邁蘭（維亞特里斯）、諾華、SHL醫療、梯瓦製藥和伊普索梅德控股環境等主要公司的概況，以及該行業的競爭製藥和伊普索梅德控股環境。

本報告解答的主要問題

1. 2025年全球自動注射器市場規模有多大？

2. 2026 年至 2034 年全球自動注射器市場的預期成長率為何？

3. 推動全球自動注射器市場發展的主要因素是什麼？

4. COVID-19 對全球自動注射器市場有何影響？

5. 全球自動注射器市場按類型分類的組成是什麼？

6. 全球自動注射器市場按應用領域分類的詳細情形如何？

7. 全球自動注射器市場依最終用戶分類的情況如何？

8. 全球汽車噴油嘴市場的主要區域有哪些？

9. 全球自動注射器市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球自動注射器市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 一次性自動注射器
  • 可重複使用的自動注射器

第7章 市場區隔：依應用領域分類

  • 類風濕性關節炎
  • 過敏反應
  • 多發性硬化症
  • 其他

第8章 市場區隔：依最終用戶分類

  • 居家照護環境
  • 醫院和診所

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Amgen Inc.
    • Antares Pharma Inc.
    • Becton Dickinson and Company
    • Bristol-Myers Squibb Company
    • Eisai Co. Ltd.
    • Eli Lilly and Company
    • Haselmeier GmbH（Sulzer Ltd.）
    • Johnson & Johnson
    • Mylan NV（Viatris Inc.）
    • Novartis AG
    • SHL Medical AG
    • Teva Pharmaceutical Industries Ltd.
    • Ypsomed Holding AG
Product Code: SR112026A5436

The global autoinjector market size reached USD 2.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.7 Billion by 2034, exhibiting a growth rate (CAGR) of 12.67% during 2026-2034. The increasing prevalence of chronic diseases, continuous advancements in biologics and biosimilars, the rising preference for home healthcare, numerous product innovations, and supportive reimbursement policies, are some of the factors driving the market.

Autoinjectors are self-injectable devices that help deliver drugs via the subcutaneous or intramuscular route. They offer several advantages, such as dosage accuracy and improved patient compliance, and help reduce needle phobia of patients, lower needlestick injuries resulting from a hidden needle, and increase the convenience and efficiency of healthcare professionals. They are widely used during emergency conditions, such as anaphylaxis, migraine, status epilepticus, psoriasis, diabetes, multiple sclerosis, and rheumatoid arthritis. As a result, autoinjectors find extensive applications in hospitals, clinics, and home care centers across the globe.

Autoinjector Market Trends:

At present, there is a rise in the prevalence of arthritis, asthma, cancer, chronic obstructive pulmonary disease (COPD) and Alzheimer's disease. This, along with the growing need for self-administrating medicines, represents one of the key factors driving the market. Moreover, governments of several countries are undertaking initiatives to promote the use of autoinjectors in schools. This, coupled with the increasing awareness among individuals about the benefits of autoinjectors, is propelling the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to develop simple, cost-effective, and new technology-based autoinjectors for treating rheumatoid arthritis and multiple sclerosis. Besides this, the rising adoption of targeted therapies to alter proteins within cancer cells and prevent the formation of new blood vessels in the tumor is offering lucrative growth opportunities to industry investors. Additionally, the burgeoning healthcare industry around the world is bolstering the growth of the market. Some of the other factors inducing growth are the increasing number of regulatory approvals, technological advancements, patent expiry of biologics and the availability of generic versions of autoinjectors.

Market Segmentation:

This report provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. The report categorizes the market based on type, application, and end user.

Breakup by Type:

  • Disposable Autoinjectors
  • Reusable Autoinjectors

Breakup by Application:

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others

Breakup by End User:

  • Home Care Settings
  • Hospitals and Clinics

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG, SHL Medical AG, Teva Pharmaceutical Industries Ltd. and Ypsomed Holding AG.

Key Questions Answered in This Report

1. What was the size of the global autoinjector market in 2025?

2. What is the expected growth rate of the global autoinjector market during 2026-2034?

3. What are the key factors driving the global autoinjector market?

4. What has been the impact of COVID-19 on the global autoinjector market?

5. What is the breakup of the global autoinjector market based on the type?

6. What is the breakup of the global autoinjector market based on the application?

7. What is the breakup of the global autoinjector market based on the end user?

8. What are the key regions in the global autoinjector market?

9. Who are the key players/companies in the global autoinjector market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Autoinjector Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Disposable Autoinjectors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reusable Autoinjectors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Rheumatoid Arthritis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Anaphylaxis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Multiple Sclerosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Home Care Settings
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals and Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amgen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Antares Pharma Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eisai Co. Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Eli Lilly and Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Haselmeier GmbH (Sulzer Ltd.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Mylan N.V. (Viatris Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Novartis AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 SHL Medical AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teva Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Ypsomed Holding AG
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Autoinjector Market: Major Drivers and Challenges
  • Figure 2: Global: Autoinjector Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Autoinjector Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Autoinjector Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Autoinjector Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Autoinjector Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Autoinjector Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Autoinjector (Disposable Autoinjectors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Autoinjector (Disposable Autoinjectors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Autoinjector (Reusable Autoinjectors) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Autoinjector (Reusable Autoinjectors) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Autoinjector (Rheumatoid Arthritis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Autoinjector (Rheumatoid Arthritis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Autoinjector (Anaphylaxis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Autoinjector (Anaphylaxis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Autoinjector (Multiple Sclerosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Autoinjector (Multiple Sclerosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Autoinjector (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Autoinjector (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Autoinjector (Home Care Settings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Autoinjector (Home Care Settings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Autoinjector (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Autoinjector (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Autoinjector Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Autoinjector Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Autoinjector Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Autoinjector Industry: SWOT Analysis
  • Figure 74: Global: Autoinjector Industry: Value Chain Analysis
  • Figure 75: Global: Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Autoinjector Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Autoinjector Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Autoinjector Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Autoinjector Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Autoinjector Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Autoinjector Market: Competitive Structure
  • Table 7: Global: Autoinjector Market: Key Players